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Abstract
The introduction of routine vaccination against tetanus and diphtheria
in Brazil has decreased the incidence and changed the epidemiology
of both diseases. We then investigated the prevalence of Corynebac-
terium diphtheriae carrier status and diphtheria and tetanus immunity
in São Paulo, Brazil. From November 2001 to March 2003, 374
individuals were tested for the presence of C. diphtheriae in the naso-
oropharynx and of serum diphtheria and tetanus antibodies. Partici-
pants were all healthy individuals without acute or chronic patholo-
gies and they were stratified by age as follows: 0-12 months and 1-4,
5-9, 10-14, 15-24, 25-39, 40-59, and ≥60 years. Antibodies were
assessed using a double-antigen ELISA. C. diphtheriae species were
identified by biochemical analysis and toxigenicity was assessed by
the Elek test. For diphtheria, full protection (antibodies ≥0.1 IU/mL)
was present in 84% of the individuals, 15% had basic protection
(antibodies ≥0.01 and <0.1 IU/mL) and 1% were susceptible (anti-
bodies <0.01 IU/mL). Full tetanus protection (antibodies ≥0.1 IU/mL)
was present in 79% of the participants, 18% had basic protection
(antibodies ≥0.01 and <0.1 IU/mL) and 3% were susceptible (anti-
bodies <0.01 IU/mL). The geometric mean of diphtheria and tetanus
antibodies reached the highest values at 5-9 years and decreased until
the 40-59-year age range, increasing again in individuals over 60
years. Three participants (0.8%) were carriers of C. diphtheriae, all
non-toxigenic strains. The present results demonstrate the clear need
of periodic booster for tetanus and diphtheria vaccine in adolescents
and adults after primary immunization in childhood.
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Prior to the availability of a vaccination,
immunity against diphtheria occurred through
infection in childhood and was maintained
in adulthood by frequent natural boosters
from exposure to toxigenic strains of the
diphtheria bacilli (1). The introduction of
routine vaccination in many countries
changed the epidemiology of diphtheria, so
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that immunity against the disease is now
provided by primary vaccination during the
first months of life. Immunization led to a
marked decrease in the incidence of the dis-
ease and to a subsequent decrease in the
reservoir of toxigenic Corynebacterium diph-
theriae organisms (1). In this setting, immu-
nity against diphtheria can only be main-
tained in adults if routine booster doses of
diphtheria toxoid are administered.
Moreover, vaccination coverage must be
high and uniform in all age groups, so that
pools of susceptible individuals do not form.
When an imported source of infection oc-
curs, the presence of susceptible groups can
favor the circulation of C. diphtheriae toxi-
genic strains. Eventually, that can cause a
diphtheria epidemic as the one that occurred
recently in the newly independent states of
the former Soviet Union (2).
In view of this, routine epidemiological
surveys help check the maintenance of the
protective antibody levels against the dis-
ease. Interestingly, since tetanus and diph-
theria toxoids are administered together,
immunity against both diseases tends to de-
velop concomitantly, although not at the
same intensity.
In the present study, we have assessed
the prevalence of diphtheria and tetanus anti-
bodies and the circulation of C. diphtheriae
in São Paulo, Brazil. The investigation was
conducted from September 2001 to March
2003 at the Federal University of São Paulo
and at the Adolfo Lutz Institute, São Paulo,
Brazil. The Ethics Committee of both insti-
tutions approved the protocol and written
informed consent was obtained from each
subject before enrollment.
The participants were 374 individuals
(146 males and 228 females) stratified by
age: 0 to 12 months (N = 20), 1 to 4 (N = 49),
5 to 9 (N = 54), 10 to 14 (N = 35), 15 to 24 (N
= 48), 25 to 39 (N = 65), 40 to 59 (N = 50),
and 60 years or older (N = 53).
Individuals were recruited using a con-
venience sampling method at Cruz de Malta
Center (60%) and at the Federal University
of São Paulo (40%), in the city of São Paulo,
SP, Brazil. They were all healthy individu-
als. Exclusion criteria were presence of acute
infectious diseases, cancer, congenital or
acquired immune deficiency, use of antibi-
otics in the previous 15 days, hospitalization
for more than 24 h in the previous 30 days,
and living in an institution.
A form was completed with age and his-
tory of previous immunization. Five millili-
ters of venous blood was collected from all
participants on entry into the study. Serum
samples were separated and stored at -80ºC
until testing.
Calcium alginate swabs (DME, Araçatu-
ba, SP, Brazil) were used to collect samples,
one from the nasopharynx and the other
from the oropharynx. The samples were im-
mediately placed on a dish with cystine and
tellurite blood agar and incubated for 48 h at
37ºC. When skin wounds were present, swab
samples were also collected.
Serologic assays were performed at the
Research Laboratory of the Pediatric Infec-
tious Diseases Division, Federal University
of São Paulo, Brazil. Diphtheria and tetanus
antibodies were measured by an in-house
double-antigen ELISA as described by
Kristiansen et al. (3), which shows a good
correlation with established toxin neutraliz-
ing assays and is functionally specific for
IgG antibodies. For diphtheria antibodies,
50 ng/mL diphtheria toxoid (Butantan Insti-
tute, São Paulo, SP, Brazil) diluted in 0.1 M
carbonate-bicarbonate buffer, pH 9.6, was
used to coat 96-well microtiter plates (Ther-
molab Systems, Vantaa, Finland) overnight
at 4ºC. Two-fold serial dilutions of serum
samples and of diphtheria reference serum
(in-house standard calibrated against “Diph-
theria antitoxin human serum 91/534” -
NIBSC reagent) in dilution buffer (0.01 M
PBS, pH 7.2, and 1% Triton X-100) with 1%
bovine serum albumin were added to the
plate and incubated for 1 h at 37ºC. For the
next step, biotin-labeled diphtheria toxoid in
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dilution buffer was added to the plate and
incubated for an additional 1 h at 37ºC.
Streptavidin-alkaline phosphatase conjugate
(Zymed, San Francisco, CA, USA) in dilu-
tion buffer was incubated for 1 h at 37ºC. p-
Nitrophenyl-phosphate (Sigma, St. Louis,
MO, USA) in 1 M diethanolamine and 5 mM
magnesium chloride buffer, pH 9.8, was used
as substrate and absorbance was read at 450
nm in an immunoreader ELX-800 (Bio-Tek
Instruments, Winooski, VT, USA). Between
steps, the plate was washed five times using
a dilution buffer.
For tetanus antibodies, the same method
was applied with some modifications: 80 ng/
mL tetanus toxoid (Butantan Institute), teta-
nus reference serum (in-house standard cali-
brated against “Tetanus antitoxin human
immunoglobulin NIBSC reagent 1976 (76/
589)”) and biotin-labeled tetanus toxoid were
used as substitutes for the corresponding
diphtheria reagents. Diphtheria and tetanus
antibodies were reported in international units
per milliliter (IU/mL) using the curve com-
parison method to transform absorbance to
concentration units.
Intra-assay coefficients varied from 1.8
to 2.7% for diphtheria ELISA and from 0.9
to 3.2% for tetanus ELISA. Inter-assay varia-
tion varied from 4.9 to 15.2% for diphtheria
ELISA and from 8.9 to 47.5% for tetanus
ELISA. Higher coefficients were only found
among samples of very low antibody levels
(e.g., 0.011 IU/mL), so that they did not
interfere with results.
Patients were classified according to in-
ternationally accepted criteria of protective
antibody levels (4,5). Individuals with diph-
theria and tetanus antibody concentrations
lower than 0.01 IU/mL were considered to
be without protection and individuals with
levels equal to or greater than 0.1 IU/mL
were considered to be fully protected. Those
with antibodies equal to or greater than 0.01
IU/mL and less than 0.1 IU/mL were classi-
fied as having basic immunity, which pro-
tects most individuals against the disease,
but is usually considered to be a short-term
protection.
The microbiological characterization of
the bacteria was done according to the Cen-
ters for Disease Control and Prevention
Manual (6) with some modifications intro-
duced at the Adolfo Lutz Institute in their
routine identification of C. diphtheriae. Af-
ter 48 h of incubation at 37ºC, in the event of
growth of characteristic colonies, which
could vary from a grayish color to a darker
one, four colonies were transferred to four
different Pai medium slants and incubated
for 24 h at 37ºC. After this procedure, if the
colony remained the same color as the medi-
um and had a butter consistence, a scrape of
the Pai medium was obtained and trans-
ferred to a Pisu medium to detect production
of H2S. Simultaneously, the Albert-Laybourn
color test was performed to check for the
presence of metachromatic granules; if pres-
ent, the C. diphtheriae would appear as green
or blue color, sometimes chestnut brown.
The diphtheria bacilli were identified after
biochemical tests for the detection of sugar
fermentation, urea hydrolysis, nitrate reduc-
tion, and the presence of catalase and oxi-
dase. The first reading was performed at 24
h, when sugar fermentation was observed
and the nitrate enzymatic test was carried
out. The biochemical tests were incubated
for 5 days because of the possibility of later
fermentation of sugars.
In the present study, the biotypes of C.
diphtheriae were classified as gravis, mitis
and intermedius according to hemolysis in
blood agar and glucogen fermentation. The
Elek test was performed to detect the toxige-
nicity of C. diphtheriae. Results were read
within 15 days and were considered positive
for a toxigenic strain if a white precipitation
perpendicular to the strain growth was ob-
served. Control strains for C. diphtheriae
were NCTC 10356, PW8 and NCTC 12078.
Antibody levels were submitted to loga-
rithmic transformation before statistical anal-
ysis due to their non-normal distribution.
1684
Braz J Med Biol Res 40(12) 2007
K.G. Divino-Goes et al.
www.bjournal.com.br
Mean diphtheria antibody levels in different
age groups and mean diphtheria and tetanus
antibody levels in each age group were com-
pared by ANOVA. Games-Howell correc-
tion was employed to compare antibody lev-
els among age groups due to the variance
between them. ANOVA and Games-Howell
correction were performed using the SPSS
10.01 software (1999) and geometric means
and confidence interval were calculated us-
ing the STATA 7.0 software.
Overall, only 1% (5/374) of the popula-
tion studied was considered to be suscep-
tible to diphtheria; 15% (57/374) had basic
immunity and 84% (312/374) were fully
protected. For tetanus, 3% (13/374) were
susceptible, 18% (68/374) had basic immu-
nity and 79% (293/374) were fully protected
(Table 1).
Geometric mean tetanus antibody levels
were higher than diphtheria levels up to the
age range of 40 to 59 years, when they were
similar. Geometric mean diphtheria antibody
levels were higher than tetanus antibody
levels only for the age group of individuals
aged 60 years or over (Figure 1). Statistical
differences between geometric mean diph-
theria and tetanus antibody levels were ob-
served within the age group of 5 to 9 years of
age, in which children had higher tetanus
antibodies (P < 0.001) and in the age group
of 60 years or over, in which individuals had
higher geometric mean diphtheria antibody
levels (P = 0.007; Figure 1).
When mean diphtheria antibody levels
of different age groups were compared, indi-
viduals 60 years or over had higher levels
(0.94 IU/mL) than those aged 0 to 12 months
(0.09 IU/mL; Games-Howell, P > 0.001), 1
to 4 years (0.35 IU/mL; Games-Howell, P =
0.04), 25 to 39 years (0.35 IU/mL; Games-
Howell, P = 0.012), and 40 to 59 years (0.21
IU/mL; Games-Howell, P > 0.001). The 5-
to 9-year-old group (0.64 IU/mL) also had
significantly higher diphtheria antibody lev-
els than the 40- to 59-year-old group (0.21
IU/mL; Games-Howell, P = 0.004; Figure
1).
The lowest mean diphtheria antibody lev-
els were observed in children under 12
months of age (0.09 IU/mL), with a statisti-
cally significant difference when compared
to the age groups of 5 to 9 years (0.64 IU/
mL; Games-Howell, P < 0.001), 10 to 14
years (0.45 IU/mL; Games-Howell, P =
0.005), 15 to 24 years (0.47 IU/mL; Games-
Howell, P = 0.004), and 25 to 39 years (0.35
IU/mL; Games-Howell, P = 0.029; Figure 1).
Table 1. Tetanus and diphtheria antibody levels according to subject age.
Age groups Total number Categories of immunity
Diphtheria Tetanus
Full protection Basic protection No protection Full protection Basic protection No protection
(≥0.1 IU/mL) (≥0.01 and <0.1 IU/mL) (<0.01 IU/mL) (≥0.1 IU/mL) (≥0.01 and <0.1 IU/mL) (<0.01 IU/mL)
1-12 months 20 11 (55%) 7 (35%) 2 (10%) 13 (65%) 4 (20%) 3 (15%)
1-4 years 49 40 (82%) 7 (14%) 2 (4%) 45 (92%) 4 (8%) 0 (0%)
5-9 years 54 52 (96%) 2 (4%) 0 (0%) 51 (94%) 3 (6%) 0 (0%)
10-14 years 35 33 (94%) 2 (6%) 0 (0%) 31 (89%) 4 (11%) 0 (0%)
15-24 years 48 44 (92%) 4 (8%) 0 (0%) 38 (79%) 9 (19%) 1 (2%)
25-39 years 65 52 (80%) 12 (18%) 1 (2%) 49 (75%) 14 (22%) 2 (3%)
40-59 years 50 32 (64%) 18 (36%) 0 (0%) 30 (60%) 17 (34%) 3 (6%)
≥60 years 53 48 (91%) 5 (9%) 0 (0%) 36 (68%) 13 (24%) 4 (8%)
Total number 374 312 (84%) 57 (15%) 5 (1%) 293 (79%) 68 (18%) 13 (3%)
Data are reported as number with percent in parentheses.
1685
Braz J Med Biol Res 40(12) 2007
Diphtheria and tetanus immunity in Brazil
www.bjournal.com.br
For tetanus, the 5- to 9-year-old group
had higher mean antibody levels (1.28 IU/
mL) when compared to the age groups of 0
to 12 months (0.19 IU/mL; Games-Howell,
P = 0.014), 25 to 39 years (0.39 IU/mL;
Games-Howell, P = 0.002), 40 to 59 years
(0.19 IU/mL; Games-Howell, P < 0.001),
and 60 years or older (0.27 IU/mL; Games-
Howell, P < 0.001; Figure 1). The age group
of 40 to 59 years had significantly lower
levels than the age groups of 1 to 4 years
(0.74 IU/mL; Games-Howell, P = 0.001), 10
to 14 years (0.62 IU/mL; Games-Howell, P
= 0.029) and 15 to 24 years (0.69 IU/mL;
Games-Howell, P = 0.022).
Immunization rates by age stratum fol-
lowed a similar trend: 92% for 0- to 6-
month-old infants, 100% for 7- to 12-month-
old infants, 88% for 1- to 4-year-old chil-
dren, 90% for individuals aged 5 to 9 years,
89% for those aged 10 to 14 years, 59% for
those aged 15 to 24 years, 59% for those
aged 25 to 39 years, 18% for those aged 40 to
59 years, and 78% for those above 60 years
of age.
Three of 374 individuals proved to be
carriers of C. diphtheriae, one with the mitis
biotype and two with the gravis biotype, all
of them atoxigenic strains. They were two
children, aged 4 and 5 years, and a 20-year-
old female. Both children had been fully
immunized, as confirmed by their vaccina-
tion records. The woman reported not hav-
ing been previously vaccinated against teta-
nus and diphtheria. All of them had protec-
tive antibody levels against tetanus and diph-
theria. A nasopharynx and oropharynx swab
from all family members of the 3 carriers
was collected, but no C. diphtheriae strains
were found.
In Brazil, the high coverage of diphthe-
ria-tetanus-pertussis (DTP) vaccination has
led to an important reduction in the number
of diphtheria cases and deaths over the last
Figure 1. Geometric means
(GM) of diphtheria and tetanus
antibody levels as a function of
age group. CI = confidence in-
terval at 95%.
GM (CI)
Tetanus 0.19 0.74 1.28 0.62 0.69 0.39 0.19 0.27
(0.07-0.49) (0.48-1.13) (0.88-1.86) (0.36-1.07) (0.39-1.66) (0.25-0.61) (0.11-0.31) (0.16-0.47)
Diphtheria 0.09 0.35 0.64 0.45 0.47 0.35 0.21 0.94
(0.05-0.19) (0.22-0.56) (0.46-0.87) (0.32-0.64) (0.34-0.66) (0.25-0.51) (0.13-0.33) (0.62-1.42)
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two decades (7). The present immunization
schedule in Brazil includes 5 DTP doses at 2,
4, 6, 15 months, and 4-6 years of age, fol-
lowed by tetanus-diphtheria (Td) boosters
every 10 years.
In the present study, we found that only
1% of the population was susceptible to
diphtheria and 3% to tetanus. Almost all age
groups had fully protective antibodies (mean
antibody levels ≥0.1 IU/mL). The exception
was the 0- to 12-month-old group, with mean
antibody titers considered to be basic protec-
tive (0.09 IU/mL), probably because some
children still had not received the 3 DTP
doses when their blood was collected. Eight
of the 20 infants in that age range were 7
months of age or older, and only 1 child did
not have protective antibody levels against
diphtheria, but was immune to tetanus. All
of them had received 3 DTP vaccine doses.
Both mean diphtheria and tetanus anti-
bodies increased with age and reached a
peak in the 5- to 9-year-old group, when
children should have had 5 DTP doses. That
was followed by a decay in mean antibody
titers for tetanus and diphtheria, with a subtle
increase in the 15- to 24-year-old group,
suggesting that many adolescents failed to
receive the Td booster (8,9). Indeed, while
studying a group of Brazilian adolescents,
we have recently shown that higher tetanus
and diphtheria antibodies were found in those
who had up-to-date vaccination records (8).
In the United States (10) and Spain (11) the
proportion of protective antibodies against
tetanus and diphtheria also decreased from
infancy to adolescence.
From the 15- to 24-year-old group on,
mean antibody levels decreased progres-
sively until the 40- to 59-year-old group and
increased again in individuals 60 years or
over. Researchers in the United States, Tur-
key, England, and Wales also showed that
there was a decrease in the prevalence of
tetanus and diphtheria protective antibodies
from young adults to individuals 60 years or
over (10,12,13).
As previously reported by our group
(8,14) and by others (12), tetanus antibodies
elicited by vaccination are usually present in
higher concentration than diphtheria anti-
bodies. In the present study, tetanus anti-
body levels were higher than diphtheria anti-
bodies in all age groups, the only exception
being individuals over 60 years of age, who
showed geometric mean antibody concen-
trations against diphtheria well above those
for tetanus. Those subjects were born when
immunity against the disease was acquired
through infection with diphtheria bacilli, and
vaccination against diphtheria and tetanus
had not been routinely introduced. In 1999 a
National Influenza, Pneumococcus, Tetanus,
and Diphtheria Vaccination Campaign for
the Elderly was launched in Brazil, and has
been continuing every year (7,15). It is prob-
able that, for some elderly people, the Td
vaccine acted as a booster for diphtheria
even though it was part of primary immuni-
zation for tetanus (16).
The diphtheria and tetanus antibody lev-
els shown by us are in agreement with the
absence of toxigenic strains of C. diphthe-
riae in the oro-nasopharynx of the individu-
als we studied. Also, bacilli were not recov-
ered from wounds. Our results are coherent
with the decrease in diphtheria cases in São
Paulo State to rates between 0.01 to 0.05 per
100,000 inhabitants over the last 15 years
(17). Other countries with low incidence of
diphtheria have also low or no circulation of
diphtheria bacilli (18,19).
Recent studies assessing diphtheria and
tetanus antibody levels have been performed
in Brazil, but most of them included specific
population or age groups (8,14,16). It can be
argued that the present study population may
not be representative of São Paulo city. How-
ever, since it involved all age strata, it per-
mitted a comparison of immunity to tetanus
and diphtheria according to age. Our results
showed that children under 1 year and adults
40 to 59 years of age were the two groups at
higher risk for both diseases. Interestingly,
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during the diphtheria epidemic in the Re-
public of Georgia in 1993 to 1996, children
who did not have the complete primary vac-
cination series with diphtheria toxoid and
adults between 40 and 49 years of age were
those with the highest fatality rate among the
659 patients identified with diphtheria (20).
These findings highlight the need for
maintenance of protective antibody levels
through basic immunization in children. Ef-
forts must also be undertaken to encourage
boosters in adolescents and adults. In the
case of the Brazilian population, that seems
especially important for the 40- to 59-year
age stratum.
